In today’s recent session, 0.9 million shares of the Acelyrin Inc (NASDAQ:SLRN) have been traded, and its beta is 1.76. Most recently the company’s share price was $1.99, and it changed around -$0.05 or -2.70% from the last close, which brings the market valuation of the company to $199.89M. SLRN at last check was trading at a discount to its 52-week high of $8.89, offering almost -346.73% off that amount. The share price’s 52-week low was $1.86, which indicates that the recent value has risen by an impressive 6.53% since then. We note from Acelyrin Inc’s average daily trading volume that its 10-day average is 2.58 million shares, with the 3-month average coming to 1.31 million.
Acelyrin Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.50. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 3 recommended SLRN as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Acelyrin Inc is expected to report earnings per share of -0.73 for the current quarter.
Acelyrin Inc (NASDAQ:SLRN) trade information
Instantly SLRN has been showing red trend so far today with a performance of -2.70% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.28 on recent trading dayincreased the stock’s daily price by 12.72%. The company’s shares are currently down -36.78% year-to-date, but still up 3.39% over the last five days. On the other hand, Acelyrin Inc (NASDAQ:SLRN) is -7.24% down in the 30-day period. We can see from the shorts that 6.53 million shares have been sold at a short interest cover period of 4.09 day(s).
The consensus price target as assigned by Wall Street analysts is $10.5, which translates to bulls needing to increase their stock price by 81.05% from its current value. Analyst projections state that SLRN is forecast to be at a low of $6 and a high of $15.
Acelyrin Inc (NASDAQ:SLRN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 8.82% of Acelyrin Inc shares, and 98.91% of them are in the hands of institutional investors. The stock currently has a share float of 108.48%.
Price (T.Rowe) Small-Cap Value Fund and Price (T.Rowe) Small Cap Stock Fund were the top two Mutual Funds as of Sep 30, 2024. The former held 2.84 shares worth $5.49 million, making up 2.83% of all outstanding shares. On the other hand, Price (T.Rowe) Small Cap Stock Fund held roughly 2.59 shares worth around $5.01 million, which represents about 2.58% of the total shares outstanding.
